Angiomax Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Bivalirudin in Acute Myocardial Infarction
Condition:   To Evaluate the Efficacy and Safety of Bivalirudin in AMI Patients With DES Interventions:   Drug: Bivalirudin;   Drug: heparin Sponsor:   Shenzhen Salubris Pharmaceuticals Co., Ltd. Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2016 Category: Research Source Type: clinical trials